- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07711821
PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care (PRIMARY-HF)
PRIMARY-HF: Diagnóstico de Insuficiência Cardíaca em Cuidados de Saúde Primários Utilizando Ecografia Point-of-Care e Péptidos Natriuréticos
The goal of this clinical trial is to evaluate whether the use of NT-proBNP testing and point-of-care ultrasound (POCUS) can improve the diagnosis and management of heart failure in adults aged 50 years or older with suspected heart failure or cardiovascular risk factors in primary care settings.
The main questions it aims to answer are:
- Does the use of NT-proBNP and/or POCUS increase the rate of new heart failure diagnoses compared with standard care?
- Does this approach support earlier initiation of guideline-directed medical therapy and improve patients' quality of life?
Researchers will compare standard care alone with standard care combined with NT-proBNP testing, POCUS, or both, to assess their impact on diagnosis and management of heart failure.
Participants will:
- Be randomly assigned to one of four groups (standard care, NT-proBNP, POCUS, or both).
- Undergo clinical evaluation for heart failure according to their assigned group.
- Be followed for 12 months with periodic assessments of quality of life and treatment adherence.
Visão geral do estudo
Status
Condições
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Jonathan dos Santos, MD.
- E-mail: jonathan.santos@ua.pt
Locais de estudo
-
-
-
Amadora, Portugal
- Ainda não está recrutando
- Unidade de Saúde Familiar Conde da Lousã
-
Contato:
- Miguel Henriques
- Número de telefone: (+351) 914 338 519
- E-mail: miguelcachinho@gmail.com
-
Lisbon, Portugal
- Ainda não está recrutando
- Unidade de Saúde Familiar do Parque
-
Contato:
- Joana Gonçalves
- Número de telefone: (+351) 961 703 789
- E-mail: joana.goncalves@ulssm.min-saude.pt
-
Lisbon, Portugal
- Ainda não está recrutando
- Unidade de Saúde Familiar Rodrigues Miguéis
-
Contato:
- Inês Santos
- Número de telefone: (+351) 911 178 033
- E-mail: inessalmeidasantos@gmail.com
-
Porto, Portugal
- Recrutamento
- Unidade de Saúde Familiar Garcia Orta
-
Contato:
- Rita Queirós
- Número de telefone: (+351) 917 257 162
- E-mail: queiros.rita.ana@gmail.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Adults aged ≥50 years
- Suspected heart failure (based on signs and/or symptoms) OR
Presence of at least two cardiovascular risk factors, including:
- Diabetes mellitus
- Arterial hypertension
- Estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m²
- Albuminuria
- Coronary artery disease or prior myocardial infarction or coronary revascularization
- Stroke or transient ischemic attack
- Atrial fibrillation or flutter
- Left ventricular hypertrophy or Q waves on electrocardiogram
- Obesity (body mass index ≥30 kg/m²)
- Ability to provide written informed consent
Exclusion Criteria:
- Known heart failure under active hospital-based follow-up
- Terminal illness or life expectancy <1 year
- Severe comorbid conditions limiting participation or follow-up
- Inability to provide informed consent
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Diagnóstico
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Standard of care
Participants receive standard clinical evaluation and management in primary care without NT-proBNP testing and without point-of-care ultrasound (POCUS).
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
|
|
Comparador Ativo: Standard of care + NT-proBNP
Participants receive standard clinical evaluation and management in primary care with NT-proBNP testing, but without point-of-care ultrasound (POCUS).
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
Measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in blood as part of the diagnostic evaluation for suspected heart failure in primary care.
|
|
Experimental: Standard of care + NT-proBNP + POCUS
Participants receive standard clinical evaluation and management in primary care with NT-proBNP testing and cardiac point-of-care ultrasound (POCUS).
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
Measurement of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in blood as part of the diagnostic evaluation for suspected heart failure in primary care.
Cardiac point-of-care ultrasound performed by trained primary care physicians to assess cardiac structure and function as part of the diagnostic evaluation for suspected heart failure.
|
|
Experimental: Standard of care + POCUS
Participants receive standard clinical evaluation and management in primary care with cardiac point-of-care ultrasound (POCUS), but without NT-proBNP testing.
|
Usual clinical evaluation and management in primary care according to standard practice, without additional diagnostic interventions specified in the study.
Cardiac point-of-care ultrasound performed by trained primary care physicians to assess cardiac structure and function as part of the diagnostic evaluation for suspected heart failure.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
New Heart Failure Diagnosis
Prazo: From baseline to 12 months
|
Proportion of participants with a new diagnosis of heart failure established during follow-up based on clinical evaluation and diagnostic testing according to routine practice.
|
From baseline to 12 months
|
|
Initiation of Guideline-Directed Medical Therapy (GDMT)
Prazo: From baseline to 12 months
|
Proportion of participants in whom guideline-directed medical therapy for heart failure is initiated during follow-up.
|
From baseline to 12 months
|
|
Change in Health-Related Quality of Life (KCCQ-12)
Prazo: From baseline to 12 months
|
Change from baseline in health-related quality of life as measured by the Kansas City Cardiomyopathy Questionnaire 12 (KCCQ-12) score.
|
From baseline to 12 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Cost-effectiveness of diagnostic strategies
Prazo: From baseline to 12 months
|
Evaluation of the cost-effectiveness of diagnostic strategies incorporating NT-proBNP testing and/or point-of-care ultrasound (POCUS), including direct healthcare costs (e.g., diagnostic testing and referrals) and indirect costs (e.g., patient time and productivity loss).
|
From baseline to 12 months
|
|
Quality of Cardiac POCUS Examinations
Prazo: From baseline to 12 months
|
Assessment of the quality and interpretability of cardiac point-of-care ultrasound (POCUS) examinations performed by trained primary care physicians, based on expert review.
|
From baseline to 12 months
|
|
Healthcare Resource Utilization
Prazo: From baseline to 12 months
|
Assessment of healthcare resource utilization, including the number of conventional echocardiograms performed and referrals to specialist care.
|
From baseline to 12 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Jonathan dos Santos, Aveiro University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- PRIMARY-HF
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .